How do gastroenterologists assess overall activity of eosinophilic esophagitis in adult patients?

[1]  D. Gladman,et al.  Factors Explaining the Discrepancy Between Physician and Patient Global Assessment of Joint and Skin Disease Activity in Psoriatic Arthritis Patients , 2015, Arthritis care & research.

[2]  S. Travis,et al.  Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity. , 2014, Gastrointestinal endoscopy clinics of North America.

[3]  A. Schoepfer,et al.  Eosinophilic esophagitis: overview of clinical management. , 2014, Gastroenterology clinics of North America.

[4]  J. Woosley,et al.  A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. , 2014, Gastrointestinal endoscopy.

[5]  A. Schoepfer,et al.  Activity Assessment of Eosinophilic Esophagitis , 2014, Digestive Diseases.

[6]  A. Schoepfer,et al.  Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. , 2013, Gastroenterology.

[7]  E. Naredo,et al.  Patient self-assessment and physician's assessment of rheumatoid arthritis activity: which is more realistic in remission status? A comparison with ultrasonography. , 2013, Rheumatology.

[8]  J. Smolen,et al.  Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity. , 2012, Arthritis & Rheumatism.

[9]  A. Pariser,et al.  Cross-sector sponsorship of research in eosinophilic esophagitis: a collaborative model for rational drug development in rare diseases. , 2012, The Journal of allergy and clinical immunology.

[10]  A. Straumann,et al.  Working with the US Food and Drug Administration: progress and timelines in understanding and treating patients with eosinophilic esophagitis. , 2012, The Journal of allergy and clinical immunology.

[11]  D. Fleischer,et al.  The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis , 2012, Gut.

[12]  T. Smyrk,et al.  Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  M. Heckman,et al.  Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system , 2012, Gut.

[14]  A. Schoepfer,et al.  Monitoring inflammatory bowel disease activity: clinical activity is judged to be more relevant than endoscopic severity or biomarkers. , 2012, Journal of Crohn's & colitis.

[15]  J. Jacobs,et al.  Determinants of discordance in patients' and physicians' rating of rheumatoid arthritis disease activity , 2012, Arthritis care & research.

[16]  M. Zwahlen,et al.  Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. , 2011, The Journal of allergy and clinical immunology.

[17]  A. Schoepfer,et al.  Eosinophilic esophagitis: updated consensus recommendations for children and adults. , 2011, The Journal of allergy and clinical immunology.

[18]  A. Schoepfer,et al.  Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[19]  Samir S. Shah,et al.  Variation in Prevalence, Diagnostic Criteria, and Initial Management Options for Eosinophilic Gastrointestinal Diseases in the United States , 2011, Journal of pediatric gastroenterology and nutrition.

[20]  S. Aceves,et al.  Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. , 2010, Gastroenterology.

[21]  Pennifer Erickson,et al.  A concept taxonomy and an instrument hierarchy: tools for establishing and evaluating the conceptual framework of a patient-reported outcome (PRO) instrument as applied to product labeling claims. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[22]  A. Zinsmeister,et al.  Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[23]  M. Collins,et al.  Dissociation Between Symptoms and Histological Severity in Pediatric Eosinophilic Esophagitis , 2009, Journal of pediatric gastroenterology and nutrition.

[24]  D. Patrick,et al.  Patient-reported outcomes to support medical product labeling claims: FDA perspective. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[25]  J. Woosley,et al.  Variability in Diagnostic Criteria for Eosinophilic Esophagitis: A Systematic Review , 2007, The American Journal of Gastroenterology.

[26]  A. Straumann,et al.  Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. , 2007, Gastroenterology.

[27]  M. Dougados,et al.  Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. , 2005, Rheumatology.

[28]  A. Straumann,et al.  Eosinophilic esophagitis: escalating epidemiology? , 2005, The Journal of allergy and clinical immunology.

[29]  J. Teitelbaum.  Natural history of primary eosinophilic esophagitis: a follow up of 30 adult patients for up to 11.5 years. , 2004, Journal of pediatric gastroenterology and nutrition.

[30]  M. Abrahamowicz,et al.  Determinants of discordance between patients and physicians in their assessment of lupus disease activity. , 2003, The Journal of rheumatology.

[31]  C. Beglinger,et al.  Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? , 2003, Gastrointestinal endoscopy.

[32]  A. Straumann,et al.  [Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings]. , 1994, Schweizerische medizinische Wochenschrift.

[33]  Ikuo Hirano,et al.  Mechanical properties of the esophagus in eosinophilic esophagitis. , 2011, Gastroenterology.

[34]  K. DeVault.  Budesonide Is Effective in Adolescent and Adult Patients With Active Eosinophilic Esophagitis , 2011 .

[35]  Anand Gupte,et al.  Eosinophilic esophagitis. , 2009, World journal of gastroenterology.

[36]  T. Smyrk,et al.  Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. , 1993, Digestive diseases and sciences.